SRx Health Solutions Inc.
SRXH
$0.34
-$0.04-10.67%
AMEX
| 09/30/2025 | |||||
|---|---|---|---|---|---|
| Revenue | -401.81% | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | -401.81% | ||||
| Cost of Revenue | -421.10% | ||||
| Gross Profit | -356.51% | ||||
| SG&A Expenses | -247.93% | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | -301.04% | ||||
| Operating Income | 222.73% | ||||
| Income Before Tax | 230.25% | ||||
| Income Tax Expenses | -- | ||||
| Earnings from Continuing Operations | 239.47% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | -0.85% | ||||
| EBIT | 222.73% | ||||
| EBITDA | 210.51% | ||||
| EPS Basic | 19.94% | ||||
| Normalized Basic EPS | 250.18% | ||||
| EPS Diluted | 20.15% | ||||
| Normalized Diluted EPS | 250.18% | ||||
| Average Basic Shares Outstanding | 3.46% | ||||
| Average Diluted Shares Outstanding | 3.46% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||